Trials / Completed
CompletedNCT02413242
Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,031 (actual)
- Sponsor
- Jan Kluytmans · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Intensive Care Unit (ICU) acquired pneumonia, including ventilator-associated pneumonia, is a frequently occurring health-care associated infection, which causes considerable morbidity, mortality and health care costs. Important pathogens causing ICU pneumonia are Staphylococcus aureus and Pseudomonas aeruginosa. The epidemiology of ICU pneumonia and patient-related and contextual factors is not fully described, but is urgently needed to support the development of effective interventions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Various observed exposure(s) of interest | A risk prediction model will be developed to assess which risk factors are associated with the development of ICU pneumonia during ICU stay |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2019-04-30
- Completion
- 2019-04-30
- First posted
- 2015-04-09
- Last updated
- 2019-05-08
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02413242. Inclusion in this directory is not an endorsement.